Kemi Biotech
Chengdu
About Kemi Biotech
Kemi Biotech is a preclinical immunotherapy product development company .
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $13.8M
- Funding stage: Seed
- Last round: Seed (Feb 2025)
- Website: chimigen.com
- Phone: +86-028-85766522
Industries & Categories
Health Care, Organic, Pharmaceutical
Canonical: https://fsome.com/organization/kemi-biotech-27986 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.